Gert van der Hoek
In Memoriam - Editor, Senior Moderator
http://www.mediaindo.co.id/berita.asp?id=129016
Bio Farma was ready to get up the Factory of the Flu Vaccine
Bandung -- MIOL: PT Bio Farma will in the near future develop and build the factory of the flu vaccine that was preparations to be able to produce the bird flu vaccine (avian influenza).
"The plan as the step" in "early to face the bird flu pandemic, if Bio Farma could have produced the flu vaccine then to the front not the difficulty of could carry out the procurement of bird flu vaccin," said Director Pemasaran PT Bio Farma, Sarimudin Sulaeman, was accompanied by the Head of public relations Teddy the Hero in Bandung, on Sunday (1/4).
To build the factory of the flu vaccine, Bio Farma will buy his technology from a vaccine company in Japan.
Whereas for the development of the bird flu vaccine will be carried out in the form of help through Bappenas. However he did not name how much investment that was needed for the development of the new vaccine factory. But that was clear will be carried out.
His value of investment still could not be sent now, but at least the development of this factory of the flu vaccine was just right, so as in the future still will not depend the other factory, he said.
In the future, was aimed at the factory of the flu vaccine will get the licence from WHO where at this time as in the case of that was given to six companies multi national at this time.
"In the future was hoped Bio Farma could overcome the requirement" for the "bird flu vaccine to domestic."
This plan was very strategic, he said. The process of his production, continued he, could be carried out by Bio Farma with bought 'bulk' (the vaccine material) bird flu from overseas afterwards was carried out by the production finishing by BUMN.
He also hoped with the existence of the factory and the bird flu of the flu vaccine, could press the price of the vaccine for the domestic requirement.
The "price" of the "vaccine just was usually high, but if having the "player" just "usually more could be saved," he said.
Export
Further Sarimudin Sulaeman said, the production of the Bio Farma vaccine apart from satisfying the national requirement also exported his vaccine product overseas. He mentioned, one of the countries that used the Bio Farma vaccine product was India.
The country was in South Asia recorded used the Bio Farma vaccine of product polio around 60 percent of the national requirement or around 400 million to 450 million doses each year. "He thought around Rp225 billion."
We sold him in the form of 'bulk' henceforth was processed again by the production company of the vaccine there, he said.
Bio Farma, continued Sarimudin, was one of the companies of the polio vaccine that got the licence from WHO.
Bio Farma was ready to get up the Factory of the Flu Vaccine
Bandung -- MIOL: PT Bio Farma will in the near future develop and build the factory of the flu vaccine that was preparations to be able to produce the bird flu vaccine (avian influenza).
"The plan as the step" in "early to face the bird flu pandemic, if Bio Farma could have produced the flu vaccine then to the front not the difficulty of could carry out the procurement of bird flu vaccin," said Director Pemasaran PT Bio Farma, Sarimudin Sulaeman, was accompanied by the Head of public relations Teddy the Hero in Bandung, on Sunday (1/4).
To build the factory of the flu vaccine, Bio Farma will buy his technology from a vaccine company in Japan.
Whereas for the development of the bird flu vaccine will be carried out in the form of help through Bappenas. However he did not name how much investment that was needed for the development of the new vaccine factory. But that was clear will be carried out.
His value of investment still could not be sent now, but at least the development of this factory of the flu vaccine was just right, so as in the future still will not depend the other factory, he said.
In the future, was aimed at the factory of the flu vaccine will get the licence from WHO where at this time as in the case of that was given to six companies multi national at this time.
"In the future was hoped Bio Farma could overcome the requirement" for the "bird flu vaccine to domestic."
This plan was very strategic, he said. The process of his production, continued he, could be carried out by Bio Farma with bought 'bulk' (the vaccine material) bird flu from overseas afterwards was carried out by the production finishing by BUMN.
He also hoped with the existence of the factory and the bird flu of the flu vaccine, could press the price of the vaccine for the domestic requirement.
The "price" of the "vaccine just was usually high, but if having the "player" just "usually more could be saved," he said.
Export
Further Sarimudin Sulaeman said, the production of the Bio Farma vaccine apart from satisfying the national requirement also exported his vaccine product overseas. He mentioned, one of the countries that used the Bio Farma vaccine product was India.
The country was in South Asia recorded used the Bio Farma vaccine of product polio around 60 percent of the national requirement or around 400 million to 450 million doses each year. "He thought around Rp225 billion."
We sold him in the form of 'bulk' henceforth was processed again by the production company of the vaccine there, he said.
Bio Farma, continued Sarimudin, was one of the companies of the polio vaccine that got the licence from WHO.